(Reuters) – The U.S. Food and Drug Administration (FDA) said on Friday it has advised manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target the XBB.1.5 …
Topic:
xbb.1.5
-
-
(Reuters) – The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca’s COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5. The subvariant …
-
By Raghav Mahobe and Julie Steenhuysen (Reuters) -Over 40% of COVID-19 cases in the United States are now caused by the highly contagious Omicron XBB.1.5, data from the U.S. Centers …